Ina Frank has joined Alvotech as Vice President, Global Regulatory Affairs based out of our office in Zurich, Switzerland and reporting directly to CEO. Ina, is a chemist by training and did her PhD thesis in pharmaceutical chemistry at the Goethe University in Frankfurt before starting her career in Regulatory Affairs.
Ina’s background is as tailor-made for Alvotech. Her Regulatory Affairs experience includes 5 years at various generic companies including Stada and 5 years at Abbott/Abbvie where she as a Global Regulatory Lead for Humira was responsible for the development of various indications as well as their device. Most recently, Ina spent 3 years with Boehringer Ingelheim as Team lead for their Biosimilar development activities including the MAA submission for that companies biosimilar adalimumab program.